Whole exome sequencing results revealed that such EV-DNA carried tumor-specific genetic mutations, including those occurring on known oncogenes and tumor suppressor genes in neuroblastoma (ALK, CHD5, SHANK2, PHOX2B, TERT, FGFR1, and BRAF), and represented the entire exome [140]. This evidence concerns the gene ALK and neuroblastoma.